SCHEMBL13639450

SCHEMBL13639450

N#Cc1ccc(N)c(NS(=O)(=O)/C=C/c2ccc(Cl)c(Cl)c2)c1

nearest known ligand 0.52

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
PTGES2 Q9H7Z7 18/20 0.52
SLC22A12 Q96S37 1/20 0.38
PTPN1 P18031 1/20 0.37
CDC25B P30305 1/20 0.37
DUSP3 P51452 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3778023 0.86 PTGES2 (0.71) PTGES2
SCHEMBL3778029 0.86 PTGES2 (0.71) PTGES2
SCHEMBL3774927 0.84 PTGES2 (0.71) PTGES2
SCHEMBL3774933 0.84 PTGES2 (0.71) PTGES2
SCHEMBL13768481 0.84 PTGES2 (0.57) PTGES2
SCHEMBL13639444 0.72 PTGES2 (0.76) PTGES2SLC22A12
SCHEMBL13062159 0.71 PTGES2 (0.77) PTGES2
SCHEMBL3782945 0.70 PTGES2 (0.78) PTGES2
SCHEMBL3779099 0.70 PTGES2 (0.78) PTGES2
SCHEMBL3779094 0.70 PTGES2 (0.78) PTGES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2234993-B1 BIS- (SULF ONYLAMINO) DERIVATIVES FOR USE IN THERAPY ASTRAZENECA AB (SE) 2012-11-07 EP disclosed